Score Overview
Explore the 2021 public Archive ranking →
Where Kazia Therapeutics Ltd ADR has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- KZIA
2010: 87.3% · 2021: 94.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 9.60 | — |
1 Year2025-09-26 | $ 7.33 | 30.97% |
5 Years2021-09-28 | $ 576.50 | -98.33% |
10 Years2016-09-28 | $ 396.00 | -97.58% |
20 Years2006-09-28 | $ 3.89K | -99.75% |
All Time1999-01-06 | $ 2.61K | -99.63% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time1999-01-06 |
|---|---|---|---|---|---|---|
| Price | $ 9.60 | $ 7.33 | $ 576.50 | $ 396.00 | $ 3.89K | $ 2.61K |
| Return | — | 30.97% | -98.33% | -97.58% | -99.75% | -99.63% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in AUD
| Year | |||
|---|---|---|---|
| TTM | $ 42K | -$ 32M | $ 69M |
| 2025 | $ 42K | -$ 20M | $ 4M |
| 2024 | $ 2M | -$ 26M | $ 1M |
| 2023 | -$ 20M | $ 5M | |
| 2022 | $ 10K | -$ 25M | $ 7M |
| 2021 | -$ 8M | $ 27M | |
| 2020 | $ 988.11K | -$ 12M | $ 8M |
| 2019 | -$ 10M | $ 5M | |
| 2018 | -$ 6M | $ 5M | |
| 2017 | $ 8M | -$ 10M | $ 14M |
| 2016 | $ 4M | -$ 12M | $ 33M |
| 2015 | $ 89K | -$ 7M | $ 44M |
| 2014 | $ 87K | -$ 7M | $ 2M |
| 2013 | $ 1M | -$ 1M | $ 8M |
| 2012 | $ 1M | $ 1M | $ 8M |
| 2011 | $ 2M | -$ 6M | $ 6M |
| 2010 | $ 9M | -$ 12M | $ 15M |
| 2009 | $ 11M | -$ 18M | $ 33M |
| 2008 | $ 13M | -$ 20M | $ 34M |
| 2007 | $ 17M | -$ 20M | $ 39M |
| 2006 | $ 13M | -$ 16M | $ 33M |
| 2005 | $ 17M | -$ 12M | $ 47M |
| 2004 | $ 16M | -$ 12M | $ 58M |
| 2003 | $ 32M | -$ 10M | $ 30M |
| 2002 | $ 19M | -$ 14M | $ 39M |
| 2001 | $ 58M | -$ 42M | $ 61M |
| 2000 | $ 26M | -$ 13M | $ 28M |
| IPO1999 | $ 19M | -$ 17M | $ 29M |
Kazia Therapeutics Ltd ADR fundamental performance
Between 2015 and 2025, revenue declined from $ 89K to $ 42K and net income went from -$ 7M to -$ 20M. Revenue increased in 3 of those 10 years; net income in 5.
Across Kazia Therapeutics Ltd ADR's full reported history, from 1999 to 2025, revenue declined from $ 19M to $ 42K and net income went from -$ 17M to -$ 20M. Revenue increased in 40% of the years measured; net income in 52%.
Kazia Therapeutics Ltd ADR currently holds a 20-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.
Membership
Continue KZIA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
